Synthetic Biology towards Improved Flavonoid Pharmacokinetics

Flavonoids are a structurally diverse class of natural products that have been found to have a range of beneficial activities in humans. However, the clinical utilisation of these molecules has been limited due to their low solubility, chemical stability, bioavailability and extensive intestinal met...

Full description

Bibliographic Details
Main Authors: Moon Sajid, Chaitanya N. Channakesavula, Shane R. Stone, Parwinder Kaur
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/5/754
id doaj-c9bc53ae406f420a9d7654c641a9b6f7
record_format Article
spelling doaj-c9bc53ae406f420a9d7654c641a9b6f72021-06-01T00:21:42ZengMDPI AGBiomolecules2218-273X2021-05-011175475410.3390/biom11050754Synthetic Biology towards Improved Flavonoid PharmacokineticsMoon Sajid0Chaitanya N. Channakesavula1Shane R. Stone2Parwinder Kaur3UWA School of Agriculture and Environment, The University of Western Australia, Perth, WA 6009, AustraliaUWA School of Agriculture and Environment, The University of Western Australia, Perth, WA 6009, AustraliaUWA School of Agriculture and Environment, The University of Western Australia, Perth, WA 6009, AustraliaUWA School of Agriculture and Environment, The University of Western Australia, Perth, WA 6009, AustraliaFlavonoids are a structurally diverse class of natural products that have been found to have a range of beneficial activities in humans. However, the clinical utilisation of these molecules has been limited due to their low solubility, chemical stability, bioavailability and extensive intestinal metabolism in vivo. Recently, the view has been formed that site-specific modification of flavonoids by methylation and/or glycosylation, processes that occur in plants endogenously, can be used to improve and adapt their biophysical and pharmacokinetic properties. The traditional source of flavonoids and their modified forms is from plants and is limited due to the low amounts present in biomass, intrinsic to the nature of secondary metabolite biosynthesis. Access to greater amounts of flavonoids, and understanding of the impact of modifications, requires a rethink in terms of production, more specifically towards the adoption of plant biosynthetic pathways into ex planta synthesis approaches. Advances in synthetic biology and metabolic engineering, aided by protein engineering and machine learning methods, offer attractive and exciting avenues for ex planta flavonoid synthesis. This review seeks to explore the applications of synthetic biology towards the ex planta biosynthesis of flavonoids, and how the natural plant methylation and glycosylation pathways can be harnessed to produce modified flavonoids with more favourable biophysical and pharmacokinetic properties for clinical use. It is envisaged that the development of viable alternative production systems for the synthesis of flavonoids and their methylated and glycosylated forms will help facilitate their greater clinical application.https://www.mdpi.com/2218-273X/11/5/754flavonoidspharmacokineticsanticancer compoundsex planta synthesis
collection DOAJ
language English
format Article
sources DOAJ
author Moon Sajid
Chaitanya N. Channakesavula
Shane R. Stone
Parwinder Kaur
spellingShingle Moon Sajid
Chaitanya N. Channakesavula
Shane R. Stone
Parwinder Kaur
Synthetic Biology towards Improved Flavonoid Pharmacokinetics
Biomolecules
flavonoids
pharmacokinetics
anticancer compounds
ex planta synthesis
author_facet Moon Sajid
Chaitanya N. Channakesavula
Shane R. Stone
Parwinder Kaur
author_sort Moon Sajid
title Synthetic Biology towards Improved Flavonoid Pharmacokinetics
title_short Synthetic Biology towards Improved Flavonoid Pharmacokinetics
title_full Synthetic Biology towards Improved Flavonoid Pharmacokinetics
title_fullStr Synthetic Biology towards Improved Flavonoid Pharmacokinetics
title_full_unstemmed Synthetic Biology towards Improved Flavonoid Pharmacokinetics
title_sort synthetic biology towards improved flavonoid pharmacokinetics
publisher MDPI AG
series Biomolecules
issn 2218-273X
publishDate 2021-05-01
description Flavonoids are a structurally diverse class of natural products that have been found to have a range of beneficial activities in humans. However, the clinical utilisation of these molecules has been limited due to their low solubility, chemical stability, bioavailability and extensive intestinal metabolism in vivo. Recently, the view has been formed that site-specific modification of flavonoids by methylation and/or glycosylation, processes that occur in plants endogenously, can be used to improve and adapt their biophysical and pharmacokinetic properties. The traditional source of flavonoids and their modified forms is from plants and is limited due to the low amounts present in biomass, intrinsic to the nature of secondary metabolite biosynthesis. Access to greater amounts of flavonoids, and understanding of the impact of modifications, requires a rethink in terms of production, more specifically towards the adoption of plant biosynthetic pathways into ex planta synthesis approaches. Advances in synthetic biology and metabolic engineering, aided by protein engineering and machine learning methods, offer attractive and exciting avenues for ex planta flavonoid synthesis. This review seeks to explore the applications of synthetic biology towards the ex planta biosynthesis of flavonoids, and how the natural plant methylation and glycosylation pathways can be harnessed to produce modified flavonoids with more favourable biophysical and pharmacokinetic properties for clinical use. It is envisaged that the development of viable alternative production systems for the synthesis of flavonoids and their methylated and glycosylated forms will help facilitate their greater clinical application.
topic flavonoids
pharmacokinetics
anticancer compounds
ex planta synthesis
url https://www.mdpi.com/2218-273X/11/5/754
work_keys_str_mv AT moonsajid syntheticbiologytowardsimprovedflavonoidpharmacokinetics
AT chaitanyanchannakesavula syntheticbiologytowardsimprovedflavonoidpharmacokinetics
AT shanerstone syntheticbiologytowardsimprovedflavonoidpharmacokinetics
AT parwinderkaur syntheticbiologytowardsimprovedflavonoidpharmacokinetics
_version_ 1721415166264868864